Microdosing GLP-1s Like Wegovy, Zepbound May Still Lead to Weight Loss
Research shows that microdosing GLP-1 medications may still lead to weight loss. Tatsiana Volkava · Moment/Getty Recent research suggests that people may still lose weight while staying on the lowest starting doses of GLP-1 medications, such as Wegovy or Zepbound, for longer periods. After one year, people taking sustained low dose tirzepatide lost about 5.5% of their body weight, while those…
We haven't written up this one. Healthline News has the full story — the link below goes straight to it.
